-Inborn BioMedical was co-founded by entrepreneurs originating from the Regenerative Biomaterials research group at Radboudumc to translate advanced basic research towards impactful solutions for patients. Our Nanoparticle-Based Gel (NBG) harnesses cutting-edge nanotechnology to deliver effective, safe, and long-lasting therapy, addressing the unique challenges of bone infections. Driven by this goal, Inborn BioMedical bridges the gap between innovative science and real-world medical needs.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Reinier Postlaan 2, Nijmegen,gelderland 6525 Gc,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- nanotechnology, biomaterials, colloidal gel, hydroxyapatite, gelatin, bone infections, bone cancer, tissue regeneration, intracellular infections.
- HQ
- Nijmegen, Gelderland
Inborn Biomedical Questions
Inborn Biomedical's website is https://www.inbornbiomedical.com/
Inborn Biomedical's LinkedIn profile is https://nl.linkedin.com/company/inbornbiomedical
Inborn Biomedical has
2 employees.
View email and phone details for 2
employees at Inborn Biomedical.
Inborn Biomedical's industry is
Biotechnology Research
Inborn Biomedical's top competitors are
Alkyl Recycling,
Leiden Nerve Center - Zenuwcentrum,
Preimure,
Twente Medical Optics,
Regen Biomedical,
Biomedical Imaging Group Rotterdam,
Radboudumc,
Ai-Hub Oost-Nederland,
Programmable Polymers Research Group,
Eggxpert.
Inborn Biomedical's categories are Biotechnology Research
Inborn Biomedical's founding year is 2024
